Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Short Communication Volume 5 Issue 1

Early Therapeutic Intervention in COVID-19 Infection May Prevent Death

Tapan K Chaudhuri* and Richard Hoffler

Hampton, VA and San Antonio, TX, USA.

*Corresponding Author: Tapan K Chaudhuri, Hampton, VA, USA. E-mail: tkchaudhuri44@gmail.com

Received: December 07, 2020; Published: December 22, 2020

Reprints View PDF Related Articles

×

  It appears that COVID-19 infection (SARS-CoV-2) has two distinct clinical phases - Early Nasopharyngial phase and Late Bronchoalveolar Phase.

×

References

×

Citation

Citation: Tapan K Chaudhuri and Richard Hoffler. “Early Therapeutic Intervention in COVID-19 Infection May Prevent Death". Acta Scientific Pharmaceutical Sciences 5.1 (2021): 94.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is November 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.